about
Structure-related inhibitory effect of antimicrobial enoxacin and derivatives on theophylline metabolism by rat liver microsomesQuinolones potentiate cefazolin-induced seizures in DBA/2 miceModulation of pharmacokinetics of theophylline by antofloxacin, a novel 8-amino-fluoroquinolone, in humans.Absence of effect of rufloxacin on theophylline pharmacokinetics in steady state.Effect of a new quinolone, sparfloxacin, on the pharmacokinetics of theophylline in asthmatic patients.In vivo and in vitro toxicodynamic analyses of new quinolone-and nonsteroidal anti-inflammatory drug-induced effects on the central nervous system.The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomesEnoxacin decreases the clearance of theophylline in man.The influence of quinolone derivatives on theophylline clearance.Effect of norfloxacin on theophylline metabolism.The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.Tissue penetration of ciprofloxacin after single and multiple doses.Reduced phototoxicity of a fluoroquinolone antibacterial agent with a methoxy group at the 8 position in mice irradiated with long-wavelength UV light.Effect of HSR-903, a new fluoroquinolone, on the concentration of theophylline in serumEffects of DU-6859a, a new quinolone antimicrobial, on theophylline metabolism in in vitro and in vivo studies.Influence of a newly developed quinolone, T-3761, on pharmacokinetics of theophylline in rats.In vitro effect of fluoroquinolones on theophylline metabolism in human liver microsomes.Safety of fleroxacin coadministered with theophylline to young and elderly volunteersEffects of enoxacin on renal and metabolic clearance of theophylline in rats.Effect of ciprofloxacin on antipyrine pharmacokinetics and metabolism in rats.Impact of ciprofloxacin on theophylline clearance and steady-state concentrations in serumInhibition of theophylline clearance by coadministered ofloxacin without alteration of theophylline effects.Lack of interaction between lomefloxacin and caffeine in normal volunteers.
P2860
Q24675730-29D5EF19-8C89-43FB-86E0-D3F8440B3666Q24680102-9D950418-BBA5-43D3-A11D-45DB31D5484FQ33566153-ECABE66A-F617-499E-AD0A-6417EE3B0EA4Q33696922-AD158D91-D109-472C-A88E-5516F9A6F0BFQ33744026-B28F94EF-3EB0-4DA1-AAD4-DBFE71AAA874Q33976215-48DF9DFE-3F64-4285-889B-161D3613BFC0Q34346464-2A84D295-B035-478B-9E7C-E6E9A1C9862DQ34447082-5C202F15-85E4-49A3-8A79-0CBF0996E2F2Q34448229-0F46998C-5DC7-4C13-A353-FE1E72937632Q35244351-9F4B86BD-12E8-46A1-A9AB-6AA0B7BE325AQ35572870-706F5F07-A862-47FE-A15C-711F288A00E9Q35649002-9048FD33-D0E8-4D20-A119-6500154D7F4EQ35897583-7B187CF1-58A5-49F4-B341-2D98E18AE3E2Q39471000-CA84AE58-E6B2-489A-B9B9-78782CF63472Q39558046-DB56836B-75B0-4F73-ADC2-E7EC48D5D7AFQ39780499-53A01060-A52F-4830-B208-738D8729447CQ39815676-65F0B601-9010-4DC4-B91A-20471E057FB1Q39816304-8CC6AAB0-34E1-4E6B-B19F-0443EDC254E2Q39816766-F9946561-33C5-41B0-A4AF-4BF9713E3A6DQ39817138-3C11F5DA-E3CA-4DF2-B0D4-0D12017F7C2DQ39817494-7B6F2110-144C-4B37-8652-2E34C5A30D56Q39827802-ABD0FA98-9449-494C-A1A6-9A759A011BB6Q40086273-1D4CA319-336C-40AC-A208-8C3F6F21ADC2
P2860
description
1984 nî lūn-bûn
@nan
1984 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Enoxacin raises plasma theophylline concentrations
@ast
Enoxacin raises plasma theophylline concentrations
@en
Enoxacin raises plasma theophylline concentrations
@nl
type
label
Enoxacin raises plasma theophylline concentrations
@ast
Enoxacin raises plasma theophylline concentrations
@en
Enoxacin raises plasma theophylline concentrations
@nl
prefLabel
Enoxacin raises plasma theophylline concentrations
@ast
Enoxacin raises plasma theophylline concentrations
@en
Enoxacin raises plasma theophylline concentrations
@nl
P2093
P1433
P1476
Enoxacin raises plasma theophylline concentrations
@en
P2093
C L van Herwaarden
W J Wijnands
P407
P577
1984-07-14T00:00:00Z